Skip to main content
Helixmith Co., Ltd logo

Helixmith Co., Ltd — Investor Relations & Filings

Ticker · 084990 ISIN · KR7084990001 KO Manufacturing
Open in API
Filings indexed 508 across all filing types
Latest filing 2019-09-10 Director's Dealing
Country KR South Korea
Listing KO 084990

About Helixmith Co., Ltd

https://www.helixmith.com/

Helixmith is a biotechnology company specializing in the research and development of gene therapies. Established in 1996, the company focuses on creating innovative biopharmaceuticals for diseases with significant unmet medical needs. Its core activities revolve around an extensive pipeline of next-generation gene therapy products. The primary therapeutic areas of focus include neurological and cardiovascular disorders, such as peripheral artery disease and coronary artery disease. Helixmith manages a comprehensive range of capabilities, from discovery and preclinical studies to clinical development of its drug candidates.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. This type of filing is a standard regulatory disclosure for insider shareholding changes, which falls under the 'Director's Dealing' category in the provided classification schema.
2019-09-10 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. This type of filing is specifically used to report changes in share ownership by company insiders (directors, executives, or major shareholders). According to the provided definitions, reports of personal share transactions by company directors and executives are classified as 'Director's Dealing' (DIRS).
2019-09-10 Korean
기타경영사항(특허권취득)(자율공시)(HGF 이형체를 이용한 당뇨병성 신경병증의 유전자치료)
Regulatory Filings Classification · 95% confidence The document is a voluntary disclosure (자율공시) regarding the acquisition of a patent (특허권 취득) by Helixmith. It details the patent name, content, and utilization plan. Since it does not fit into specific categories like financial reports, board changes, or dividends, and is a standard regulatory disclosure of corporate activity, it falls under the general regulatory filing category.
2019-08-28 Korean
반기보고서 (2019.06)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Semi-Annual Report' (반기보고서) for the company Helixmith (헬릭스미스) for the period ending June 30, 2019. It contains detailed financial statements, management discussion and analysis, and corporate information. According to the provided definitions, a comprehensive financial report for a period shorter than a full fiscal year (like a half-year report) that contains actual financial data is classified as an Interim / Quarterly Report (IR). H1 2019
2019-08-14 Korean
증권발행실적보고서
Capital/Financing Update Classification · 100% confidence The document is a '증권발행실적보고서' (Report on the Results of Securities Issuance) filed by Helixmith Co., Ltd. with the Financial Supervisory Service (FSS) in South Korea. This document details the final results of a capital increase (rights offering), including subscription status, allocation, shareholding changes, and the use of proceeds. In the context of Korean regulatory filings (DART), this is a specific report on the outcome of a securities issuance, which falls under the category of capital and financing updates.
2019-08-13 Korean
증권발행결과(자율공시)
Share Issue/Capital Change Classification · 95% confidence The document is a formal regulatory filing titled '증권 발행결과' (Securities Issuance Result) from Helixmith. It details the completion of a capital increase (paid-in capital increase via shareholder allotment), including the number of shares issued, the total amount raised, and the payment date. This falls under the category of capital structure changes and financing updates, specifically related to share issuance.
2019-08-13 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.